Recursion Stocks Jump as JP Morgan (RXRX:NASDAQ) Updates


Republican politics and Wall Street

Douglas Rissing

Recursion pharmaceuticals (RXRX) added ~11% on Wednesday morning after JP Morgan upgraded the AI-driven biotech to Overweight from Neutral, citing blockbuster sales potential for the company’s lead asset, REC-4881.

Analyst Priyanka Grover argued that REC-4881, for which



Source link

  • Related Posts

    Down Arrow Button icon

    For the first time in a year and a half, the growth engine of America’s small business economy sputtered, with profit growth falling into negative territory in November. According to…

    Sebi Alleges Pranav Adani of Insider Trading in NDTV Open Offer: Report

    The Securities and Exchange Board of India (Sebi) has charged Pranav Adani, a senior Adani Group executive and nephew of billionaire Gautam Adani, with sharing unpublished price-sensitive information ahead of…

    Leave a Reply

    Your email address will not be published. Required fields are marked *